GSK3845097

· Adaptimmune Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK3845097, covering 2024-03-18 to 2024-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma [Phase 1]

See pricing